For example, 10 of the CanCord34 genes (i.e., ZC3H3, MROH6, TIGD5, PYCR3, ZNF623, ZNF707, CCDC166, SPATC1, HGH1, and MROH1) have no publications in regard to breast cancer in PubMed, and 2 of the CanCord34 genes, namely NRBP2 and EXOSC4, had two studies and one study in breast cancer on PubMed as of 4 January 2022. This evidence concerns the gene CCDC166 and breast carcinoma.